Its activation promotes transcription of anti-apoptotic and oncogenic effectors such as BCL-xL, XIAP, Survivin, and IL-6, thereby enhancing tumor cell survival, proliferation, and chemoresistance. The gene discussed is BIRC5; the disease is neoplasm.